Results 1 to 10 of about 418,445 (212)

A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus. [PDF]

open access: yesSci Transl Med, 2023
The repeated emergence of zoonotic human betacoronaviruses (β-CoVs) dictates the need for broad therapeutics and conserved epitope targets for countermeasure design.
Tse LV   +17 more
europepmc   +2 more sources

Growth and Quantification of MERS‐CoV Infection [PDF]

open access: bronzeCurrent Protocols in Microbiology, 2015
AbstractMiddle East respiratory syndrome coronavirus (MERS‐CoV) is an emerging highly pathogenic respiratory virus. Although MERS‐CoV only emerged in 2012, we and others have developed assays to grow and quantify infectious MERS‐CoV and RNA products of replication in vitro. MERS‐CoV is able to infect a range of cell types, but replicates to high titers
Christopher M. Coleman   +1 more
openalex   +3 more sources

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

open access: greenSaudi Medical Journal, 2017
Coronavirus memiliki famili besar yang menyebabkan penyakit pada manusia dan hewan. Pada manusia dapat menyebabkan penyakit dengan gejala mulai dari common cold sampai Severe Acute Respiratory Syndrome (SARS)
Dewi Murniati
openalex   +2 more sources

Effective inhibition of MERS-CoV infection by resveratrol [PDF]

open access: yesBMC Infectious Diseases, 2017
BackgroundMiddle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging viral pathogen that causes severe morbidity and mortality. Up to date, there is no approved or licensed vaccine or antiviral medicines can be used to treat MERS-CoV-infected
Shih‐Chao Lin   +5 more
semanticscholar   +4 more sources

Treating MERS-CoV during an outbreak [PDF]

open access: hybridThe Lancet Infectious Diseases, 2014
Christopher M. Coleman   +1 more
openalex   +3 more sources

Close relatives of MERS-CoV in bats use ACE2 as their functional receptors

open access: yesbioRxiv, 2022
Middle East Respiratory Syndrome coronavirus (MERS-CoV) and several bat coronaviruses employ Dipeptidyl peptidase-4 (DPP4) as their functional receptors1–4.
Q. Xiong   +18 more
semanticscholar   +1 more source

MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic [PDF]

open access: yesEmerging Infectious Diseases, 2016
To the Editor: Accumulating evidence indicates that dromedaries (Camelus dromedarius) are a reservoir for zoonotic transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Although numerous studies have looked at other livestock in the Middle East region, evidence for MERS-CoV infection has only been found in dromedaries (1).
Reusken, Chantal B.E.M.   +10 more
openaire   +5 more sources

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

open access: yesNature Communications, 2020
Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a severe respiratory disease associated with more than 2468 human infections and over 851 deaths in 27 countries since 2012.
T. Sheahan   +18 more
semanticscholar   +1 more source

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2020
Significance Middle East Respiratory Syndrome, caused by the MERS coronavirus (MERS-CoV), continues to cause severe respiratory disease with a high case fatality rate.
E. de Wit   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy